ProShare Advisors’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $25.8K | Sell |
|
|||||
|
2024
Q4 | $37.4K | Buy |
|
|||||
|
2024
Q3 | $62.8K | Buy |
|
|||||
|
2024
Q2 | $56.5K | Sell |
|
|||||
|
2024
Q1 | $109K | Buy |
|
|||||
|
2023
Q4 | $86.9K | Buy |
|
|||||
|
2023
Q3 | $57.3K | Buy |
|
|||||
|
2023
Q2 | $123K | Buy |
|
|||||
|
2023
Q1 | $88.9K | Sell |
|
|||||
|
2022
Q4 | $149K | Buy |
|
|||||
|
2022
Q3 | $293K | Buy |
|
|||||
|
2022
Q2 | $251K | Sell |
|
|||||
|
2022
Q1 | $267K | Buy |
|
|||||
|
2021
Q4 | $302K | Buy |
|